No evidence for metabolic syndrome and lipid profile differences in patients suffering from bipolar I disorder with and without suicide attempts

References

• Abreu LN, Lafer B, Baca-Garcia E, Oquendo MA. 2009. Suicidal ideation and suicide attempts in bipolar disorder type I: an update for the clinician. Revista Brasileira de Psiquiatria 31:271–280.
   PubMed Web of Science ®Google Scholar
• Adibhatla RM, Hatcher JF. 2008. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 49:241–268.
   PubMedGoogle Scholar
• Adibhatla RM, Hatcher JF, Dempsey RJ. 2006. Lipids and lipidomics in brain injury and diseases. AAPS J 8:E314–E321.
   PubMed Web of Science ®Google Scholar
• Asellus P, Nordström P, Jokinen J. 2010. Cholesterol and CSF 5-HIAA in attempted suicide. J Affect Disord 125:388–392.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Kuloglu M, Tezcan E, Ustundag B. 2008. Serum leptin and cholesterol values in violent and non-violent suicide attempters. Psychiatry Res 158:87–91.
   PubMed Web of Science ®Google Scholar
• Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA. 2005. Reductions in cholesterol and synaptic markers in association cortex in mood disorders. Bipol Disord 7:449–455.
   PubMed Web of Science ®Google Scholar
• Beghi M, Rosenbaum JF, Cerri C, Cornaggia CM. 2013. Risk factors for fatal and nonfatal repetition of suicide attempts: a literature review. Neuropsychiatr Dis Treat 9:1725–1736.
   PubMed Web of Science ®Google Scholar
• Bocchetta A, Chillotti C, Carboni G, Oi A, Ponti M, Del Zompo M. 2001. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr Scand 104:37–41.
   PubMed Web of Science ®Google Scholar
• Bolton JM, Robinson J, Sareen J. 2009. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions. J Affect Disord 115: 367–375.
   PubMed Web of Science ®Google Scholar
• Cardenas J, Frye MA, Marusak SL, Levander ME, Chirichigno WJ, Lewis S, et al. 2008. Modal subcomponents of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106:91–97.
   PubMed Web of Science ®Google Scholar
• Chang HH, Chou CH, Chen PS, Gean PW, Huang HC, Lin CY, et al. 2009. High prevalence of metabolic disturbances in patients with bipolar disorder in Taiwan. J Affect Disord 117:124–129.
   PubMed Web of Science ®Google Scholar
• Chen YW, Dilsaver SC. 1996. Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders. Biol Psychiatry 39:896–899.
   PubMed Web of Science ®Google Scholar
• Choi KH, Wang SM, Yeon B, Suh SY, Oh Y, Lee HK, et al. 2013. Risk and protective factors predicting multiple suicide attempts. Psychiatry Res 210:957–961.
   PubMed Web of Science ®Google Scholar
• D’Ambrosio V, Salvi V, Bogetto F, Maina G. 2012. Serum lipids, metabolic syndrome and lifetime suicide attempts in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 37:136–140.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Conti CM, Serroni N, Moschetta FS, Carano A, Salerno RM, et al. 2009. The role of cholesterol levels in mood disorders and suicide. J Biol Regul Homeost Agents 23:133–140.
   PubMed Web of Science ®Google Scholar
• De Hert M, Dekker JM, Wood D, Kahl KG, Holt RI, Möller HJ. 2009. Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC). Eur Psychiatry 24:412–424.
   PubMed Web of Science ®Google Scholar
• Depner CM, Stothard ER, Wright KP Jr. 2014. Metabolic consequences of sleep and circadian disorders. Curr Diab Rep 14:507.
   PubMed Web of Science ®Google Scholar
• Diaz-Sastre C, Baca-Garcia E, Perez-Rodriguez MM, Garcia-Resa E, Ceverino A, Saiz-Ruiz J, et al. 2007. Low plasma cholesterol levels in suicidal males: a gender- and body mass index-matched case-control study of suicide attempters and nonattempters. Prog Neuro-Psychopharmacology & Biol Psychiatry 31:901–905.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. 2005. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 7:424–430.
   PubMed Web of Science ®Google Scholar
• Fiedorowicz JG, Coryell WH. 2007. Cholesterol and suicide attempts: a prospective study of depressed inpatients. Psychiatry Res 152: 11–20.
   PubMed Web of Science ®Google Scholar
• Garbarino S, Magnavita N. 2014. Obstructive Sleep Apnea Syndrome (OSAS), metabolic syndrome and mental health in small enterprise workers. feasibility of an action for health. PLoS One 9:e97188.
   PubMed Web of Science ®Google Scholar
• Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. 2008. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord 106:197–201.
   PubMed Web of Science ®Google Scholar
• Gonda X, Pompili M, Serafini G, Montebovi F, Campi S, Dome P, et al. 2012. Suicidal behavior in bipolar disorder: epidemiology, characteristics and major risk factors. J Affect Disord 143:16–26.
   PubMed Web of Science ®Google Scholar
• Goodrich DE, Kilbourne AM, Lai Z, Post EP, Bowersox NW, Mezuk B, et al. 2012. Design and rationale of a randomized controlled trial to reduce cardiovascular disease risk for patients with bipolar disorder. Contemp Clin Trials 33:666–678.
   PubMed Web of Science ®Google Scholar
• Henderson DC, Fan X, Copeland PM, Borba CP, Daley TB, Nguyen DD, et al. 2007. A double-blind, placebo-controlled trial of sibutramine for clozapine-associated weight gain. Acta Psychiatr Scand 115: 101–105.
   PubMed Web of Science ®Google Scholar
• John AP, Koloth R, Dragovic M, Lim SC. 2009. Prevalence of metabolic syndrome among Australians with severe mental illness. Med J Aust 190:176–179.
   PubMed Web of Science ®Google Scholar
• Kato T. 2005. Mitochondrial dysfunction in bipolar disorder: from 31P-magnetic resonance spectroscopic findings to their molecular mechanisms. Int Rev Neurobiol 63:21–40.
   PubMed Web of Science ®Google Scholar
• Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR. 2010. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 12:404–413.
   PubMed Web of Science ®Google Scholar
• Kilbane EJ, Gokbayrak NS, Galynker I, Cohen L, Tross S. 2009. A review of panic and suicide in bipolar disorder: does comorbidity increase risk? J Affect Disord 115:1–10.
   PubMed Web of Science ®Google Scholar
• Kim YK, Myint AM. 2004. Clinical application of low serum cholesterol as an indicator for suicide risk in major depression. J Affect Disord 81:161–166.
   PubMed Web of Science ®Google Scholar
• Lala SV, Sajatovic M. 2012. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 25:20–25.
   PubMed Web of Science ®Google Scholar
• Lalovic A. 2007. The relationship between lipid metabolism and suicidal behaviour: clinical and molecular studies. Canada: McGill University.
   Google Scholar
• Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, Turecki G. 2007. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol 10:159–166.
   PubMed Web of Science ®Google Scholar
• Lester D. 2002. Serum cholesterol levels and suicide: a meta-analysis. Suicide Life Threat Behav 32:333–346.
   PubMed Web of Science ®Google Scholar
• Linkowski P, de Maertelaer V, Mendlewicz J. 1985. Suicidal behaviour in major depressive illness. Acta Psych Scandinavica 72: 233–238.
   PubMed Web of Science ®Google Scholar
• Maayan LA, Vakhrusheva J. 2010. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. Hum Psychopharmacol 25:133–138.
   PubMed Web of Science ®Google Scholar
• Malone KM, Haas GL, Sweeney JA, Mann JJ. 1995. Major depression and the risk of attempted suicide. J Affect Disord 34:173–185.
   PubMed Web of Science ®Google Scholar
• Marazziti D, Baroni S, Picchetti M, Landi P, Silvestri S, Vatteroni E, et al. 2012. Psychiatric disorders and mitochondrial dysfunctions. Eur Rev Med Pharmacol Sci 16:270–275.
   PubMed Web of Science ®Google Scholar
• Marcinko D, Marcinko V, Karlović D, Marcinko A, Martinac M, Begić D, Jakovljević M. 2008. Serum lipid levels and suicidality among male patients with schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:193–196.
   PubMed Web of Science ®Google Scholar
• Marx CE, Stevens RD, Shampine LJ, Uzunova V, Trost WT, Butterfield MI, et al. 2006. Neuroactive steroids are altered in schizophrenia and bipolar disorder: Relevance to pathophysiology and therapeutics. Neuropsychopharmacology 31:1249–1263.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, Kemp DE. 2012. Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry 24:69–81.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Danilewitz M, Liauw SS, Kemp DE, Nguyen HT, Kahn LS, et al. 2010. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 126:366–387.
   PubMed Web of Science ®Google Scholar
• Neves FS, Malloy-Diniz LF, Corrêa H. 2009. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? J Clin Psych 70:13–18.
   Web of Science ®Google Scholar
• Oquendo MA, Waternaux C, Brodsky B, Parsons B, Haas GL, Malone KM, Mann JJ. 2000. Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters. J Affect Disord 59:107–117.
   PubMed Web of Science ®Google Scholar
• Roix JJ, DeCrescenzo GA, Cheung PH, Ciallella JR, Sulpice T, Saha S, Halse R. 2012. Effect of the antipsychotic agent amisulpride on glucose lowering and insulin secretion. Diabetes Obes Metab 14:329–334.
   PubMed Web of Science ®Google Scholar
• Roy A. 1993. Features associated with suicide attempts in depression: a partial replication. J Affect Disord 27:35–38.
   PubMed Web of Science ®Google Scholar
• Rudd MD, Goulding JM, Carlisle CJ. 2013. Stigma and suicide warning signs. Arch Suicide Res 17:313–318.
   PubMed Web of Science ®Google Scholar
• Salvi V, Albert U, Chiarle A, Soreca I, Bogetto F, Maina G. 2008. Metabolic syndrome in Italian patients with bipolar disorder. Gen Hosp Psychiatry 30:318–323.
   PubMed Web of Science ®Google Scholar
• Sarchiapone M, Roy A, Camardese G, De Risio S. 2000. Further evidence for low serum cholesterol and suicidal behaviour. J Affect Disord 61:69–71.
   PubMed Web of Science ®Google Scholar
• Shakeri J, Farnia V, Valinia K, Hashemian AH, Bajoghli H, Holsboer-Trachsler E, Brand S. 2015. The relationship between lifetime suicide attempts, serum lipid levels, and metabolic syndrome in patients with bipolar disorders. Int J Psych in Clin Practice 19: 124–131.
   PubMed Web of Science ®Google Scholar
• Shi XF, Kondo DG, Sung YH, Hellem TL, Fiedler KK, Jeong EK, et al. 2012. Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus-31 magnetic resonance spectroscopy study. Bipolar Disord 14:607–617.
   PubMed Web of Science ®Google Scholar
• Simon GE, Hunkeler E, Fireman B, Lee JY, Savarino J. 2007. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord 9:526–530.
   PubMed Web of Science ®Google Scholar
• Stefani KM, Kim HC, Kim J, Oh K, Suh I. 2013. The influence of sex and age on the relationship between sleep duration and metabolic syndrome in Korean adults. Diabetes Res Clin Pract 102: 250–259.
   PubMed Web of Science ®Google Scholar
• Suttajit S, Paholpak S, Choovanicvong S, Kittiwattanagul K, Pratoomsri W, Srisurapanont M. 2013. Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry. Neuropsychiatr Dis Treat 9: 1751–1757.
   PubMed Web of Science ®Google Scholar
• Valtonen HM, Suominen K, Mantere O, Leppamaki S, Arvilommi P, Isometsa E. 2007. Suicidal behaviour during different phases of bipolar disorder. J Affect Disord 97:101–117.
   PubMed Web of Science ®Google Scholar
• Vuksan-Cusa B, Marcinko D, Nad S, Jakovljević M. 2009. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts. Prog Neuropsychopharmacol Biol Psychiatry 33:109–112.
   PubMed Web of Science ®Google Scholar
• Newcomer JW. 2007. Metabolic syndrome and mental illness. Am J Manag Care 13:170–177.
   PubMed Web of Science ®Google Scholar
• Young AH, Grunze H. 2013. Physical health of patients with bipolar disorder. Acta Psychiatr Scand Suppl 442:3–10.
   PubMedGoogle Scholar
• Yumru M, Savas HA, Kurt E, Kaya MC, Selek S, Savas E, et al. 2007. Atypical antipsychotic related metabolic syndrome in bipolar patients. J Affect Disord 98:247–252.
   PubMed Web of Science ®Google Scholar